Human clinical trials begun for promising, llama-derived COVID antibodies

Human clinical trials have begun in study of so-called nano-bodies, a smaller, eminently stable version of coronavirus antibodies derived from llamas. Such antibodies may be the key to saving humanity from the novel coronavirus, research has shown. Now it’s being tested in people.

from New York Daily News https://ift.tt/3kfdLKo